BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 29489754)

  • 1. The landscape of genomic alterations across childhood cancers.
    Gröbner SN; Worst BC; Weischenfeldt J; Buchhalter I; Kleinheinz K; Rudneva VA; Johann PD; Balasubramanian GP; Segura-Wang M; Brabetz S; Bender S; Hutter B; Sturm D; Pfaff E; Hübschmann D; Zipprich G; Heinold M; Eils J; Lawerenz C; Erkek S; Lambo S; Waszak S; Blattmann C; Borkhardt A; Kuhlen M; Eggert A; Fulda S; Gessler M; Wegert J; Kappler R; Baumhoer D; Burdach S; Kirschner-Schwabe R; Kontny U; Kulozik AE; Lohmann D; Hettmer S; Eckert C; Bielack S; Nathrath M; Niemeyer C; Richter GH; Schulte J; Siebert R; Westermann F; Molenaar JJ; Vassal G; Witt H; ; ; Burkhardt B; Kratz CP; Witt O; van Tilburg CM; Kramm CM; Fleischhack G; Dirksen U; Rutkowski S; Frühwald M; von Hoff K; Wolf S; Klingebiel T; Koscielniak E; Landgraf P; Koster J; Resnick AC; Zhang J; Liu Y; Zhou X; Waanders AJ; Zwijnenburg DA; Raman P; Brors B; Weber UD; Northcott PA; Pajtler KW; Kool M; Piro RM; Korbel JO; Schlesner M; Eils R; Jones DTW; Lichter P; Chavez L; Zapatka M; Pfister SM
    Nature; 2018 Mar; 555(7696):321-327. PubMed ID: 29489754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
    Ma X; Liu Y; Liu Y; Alexandrov LB; Edmonson MN; Gawad C; Zhou X; Li Y; Rusch MC; Easton J; Huether R; Gonzalez-Pena V; Wilkinson MR; Hermida LC; Davis S; Sioson E; Pounds S; Cao X; Ries RE; Wang Z; Chen X; Dong L; Diskin SJ; Smith MA; Guidry Auvil JM; Meltzer PS; Lau CC; Perlman EJ; Maris JM; Meshinchi S; Hunger SP; Gerhard DS; Zhang J
    Nature; 2018 Mar; 555(7696):371-376. PubMed ID: 29489755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
    Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
    Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The landscape of chromothripsis across adult cancer types.
    Voronina N; Wong JKL; Hübschmann D; Hlevnjak M; Uhrig S; Heilig CE; Horak P; Kreutzfeldt S; Mock A; Stenzinger A; Hutter B; Fröhlich M; Brors B; Jahn A; Klink B; Gieldon L; Sieverling L; Feuerbach L; Chudasama P; Beck K; Kroiss M; Heining C; Möhrmann L; Fischer A; Schröck E; Glimm H; Zapatka M; Lichter P; Fröhling S; Ernst A
    Nat Commun; 2020 May; 11(1):2320. PubMed ID: 32385320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing genomic differences of human cancer stratified by the TP53 mutation status.
    Wang M; Yang C; Zhang X; Li X
    Mol Genet Genomics; 2018 Jun; 293(3):737-746. PubMed ID: 29330617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
    Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
    BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Iceberg Map of germline mutations in childhood cancer: focus on primary immunodeficiencies.
    Kindler O; Quehenberger F; Benesch M; Seidel MG
    Curr Opin Pediatr; 2018 Dec; 30(6):855-863. PubMed ID: 30124581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
    Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs.
    Hadi K; Yao X; Behr JM; Deshpande A; Xanthopoulakis C; Tian H; Kudman S; Rosiene J; Darmofal M; DeRose J; Mortensen R; Adney EM; Shaiber A; Gajic Z; Sigouros M; Eng K; Wala JA; Wrzeszczyński KO; Arora K; Shah M; Emde AK; Felice V; Frank MO; Darnell RB; Ghandi M; Huang F; Dewhurst S; Maciejowski J; de Lange T; Setton J; Riaz N; Reis-Filho JS; Powell S; Knowles DA; Reznik E; Mishra B; Beroukhim R; Zody MC; Robine N; Oman KM; Sanchez CA; Kuhner MK; Smith LP; Galipeau PC; Paulson TG; Reid BJ; Li X; Wilkes D; Sboner A; Mosquera JM; Elemento O; Imielinski M
    Cell; 2020 Oct; 183(1):197-210.e32. PubMed ID: 33007263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
    Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
    BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
    Villani A; Shore A; Wasserman JD; Stephens D; Kim RH; Druker H; Gallinger B; Naumer A; Kohlmann W; Novokmet A; Tabori U; Tijerin M; Greer ML; Finlay JL; Schiffman JD; Malkin D
    Lancet Oncol; 2016 Sep; 17(9):1295-305. PubMed ID: 27501770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors.
    Akhavanfard S; Padmanabhan R; Yehia L; Cheng F; Eng C
    Nat Commun; 2020 May; 11(1):2206. PubMed ID: 32371905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.
    Chen H; Huang H; Zhao J; Wang Z; Chang M; Xue L; Zhu W; Chai Y; Li G; Wang Z; Wu H
    J Neurooncol; 2019 Jul; 143(3):369-379. PubMed ID: 31049827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic landscape of response to EGFR blockade in colorectal cancer.
    Bertotti A; Papp E; Jones S; Adleff V; Anagnostou V; Lupo B; Sausen M; Phallen J; Hruban CA; Tokheim C; Niknafs N; Nesselbush M; Lytle K; Sassi F; Cottino F; Migliardi G; Zanella ER; Ribero D; Russolillo N; Mellano A; Muratore A; Paraluppi G; Salizzoni M; Marsoni S; Kragh M; Lantto J; Cassingena A; Li QK; Karchin R; Scharpf R; Sartore-Bianchi A; Siena S; Diaz LA; Trusolino L; Velculescu VE
    Nature; 2015 Oct; 526(7572):263-7. PubMed ID: 26416732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.